Cancer Discovery

About Personal Genome Diagnostics

Personal Genome Diagnostics (PGDx) empowers the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide. PGDx was established by researchers from Johns Hopkins University who are pioneers in cancer genome sequencing and liquid biopsy technologies.


PGDx Corporate:

Megan Bailey
Vice President, Marketing

W20 Group:

Peter Duckler
Director, Media
Media Inquiries